OBJECTIVE: To estimate the incidence and nature of neuromuscular abnormalities in a representative group of ITU patients. DESIGN: Prospective sequential study. SETTING: Teaching hospital ITU. PATIENTS: 23 patients who eventually stayed > 7 days on ITU who had no contraindication to muscle biopsy and whose relatives gave informed consent. MEASUREMENTS AND RESULTS: Muscle histopathology, neurophysiological studies, record of all drugs administered, APACHE II score, organ system failure score, presence or absence of sepsis, clinical evaluation of neuromuscular problems, time to hospital discharge. Heterogeneous neuromuscular abnormalities were present in 22 out of 23 patients studied and included axonal neuropathy, denervation, generalised fibre atrophy, non-specific myopathy and necrotising myopathy. CONCLUSION: Neuromuscular abnormalities are almost invariable in longstay intensive care patients and the resulting weakness may seriously delay hospital discharge. Various abnormalities were seen but no obvious aetiological factors were identified. The origin of the abnormalities is probably multifactorial.
OBJECTIVE: To estimate the incidence and nature of neuromuscular abnormalities in a representative group of ITU patients. DESIGN: Prospective sequential study. SETTING: Teaching hospital ITU. PATIENTS: 23 patients who eventually stayed > 7 days on ITU who had no contraindication to muscle biopsy and whose relatives gave informed consent. MEASUREMENTS AND RESULTS: Muscle histopathology, neurophysiological studies, record of all drugs administered, APACHE II score, organ system failure score, presence or absence of sepsis, clinical evaluation of neuromuscular problems, time to hospital discharge. Heterogeneous neuromuscular abnormalities were present in 22 out of 23 patients studied and included axonal neuropathy, denervation, generalised fibre atrophy, non-specific myopathy and necrotising myopathy. CONCLUSION:Neuromuscular abnormalities are almost invariable in longstay intensive care patients and the resulting weakness may seriously delay hospital discharge. Various abnormalities were seen but no obvious aetiological factors were identified. The origin of the abnormalities is probably multifactorial.
Authors: M J Rennie; H S Hundal; P Babij; P MacLennan; P M Taylor; P W Watt; M M Jepson; D J Millward Journal: Lancet Date: 1986-11-01 Impact factor: 79.321
Authors: D M Russell; P M Walker; L A Leiter; A A Sima; W K Tanner; D A Mickle; J Whitwell; E B Marliss; K N Jeejeebhoy Journal: Am J Clin Nutr Date: 1984-04 Impact factor: 7.045
Authors: C F Bolton; D A Laverty; J D Brown; N J Witt; A F Hahn; W J Sibbald Journal: J Neurol Neurosurg Psychiatry Date: 1986-05 Impact factor: 10.154
Authors: B Coronel; A Mercatello; J C Couturier; P G Durand; L Holzapfell; P L Blanc; D Robert Journal: Crit Care Med Date: 1990-05 Impact factor: 7.598
Authors: T R Helliwell; J H Coakley; A J Wagenmakers; R D Griffiths; I T Campbell; C J Green; P McClelland; J M Bone Journal: J Pathol Date: 1991-08 Impact factor: 7.996
Authors: F S Leijten; A W De Weerd; D C Poortvliet; V A De Ridder; C Ulrich; J E Harink-De Weerd Journal: Intensive Care Med Date: 1996-09 Impact factor: 17.440
Authors: O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson Journal: Physiol Rev Date: 2015-07 Impact factor: 37.312
Authors: B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler Journal: J Neurol Date: 2008-02-20 Impact factor: 4.849
Authors: Christiane G Frick; Heidrun Fink; Maria L Gordan; Barbara Eckel; J A Jeevendra Martyn; Manfred Blobner Journal: Intensive Care Med Date: 2007-10-20 Impact factor: 17.440